Cochrane Clinical Answers - Access Denied - How do oral and intravenous fluoropyrimidines compare for people with colorectal cancer treated with palliative intent?

Question:How do oral and intravenous fluoropyrimidines compare for people with colorectal cancer treated with palliative intent?

THIS CLINICAL ANSWER IS NEW Published Online: 20 DEC 2017

EXCERPT of full Clinical Answer

This Cochrane Clinical Answer evaluates oral versus intravenous fluoropyrimidines for people with colorectal cancer treated with palliative intent

Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.

Are you a COCHRANE CLINICAL ANSWERS subscriber?

SUBSCRIBE NOW to read the full answer

A subscription to THE COCHRANE LIBRARY is required.